Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hagin

Showing results (51-60 of 92) with videos related to

Pageof 10
Sort By:
The Journal of Allergy and Clinical Immunology|April 17, 2021
Molecular diagnosis of childhood immune dysregulation, polyendocrinopathy, and enteropathy, and implications for clinical managementSarah K Baxter, Tom Walsh, Silvia Casadei, et al.
Neurological Research and Practice|July 17, 2025
Management of disease-modifying therapies in multiple sclerosis and comorbid rheumatoid arthritisFranz Felix Konen, Torsten Witte, Diana Ernst, et al.
Autoimmunity Reviews|March 16, 2023
Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disordersFranz Felix Konen, Nora Möhn, Torsten Witte, et al.
Science Translational Medicine|June 5, 2020
Gene editing to induce FOXP3 expression in human CD4<sup>+</sup> T cells leads to a stable regulatory phenotype and functionYuchi Honaker, Nicholas Hubbard, Yufei Xiang, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 20, 2022
The effect of a third-dose BNT162b2 vaccine on anti-SARS-CoV-2 antibody levels in immunosuppressed patientsEsther Saiag, Ayelet Grupper, Irit Avivi, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 9, 2025
Long-term safety and efficacy of once-daily berotralstat in patients with hereditary angioedema: APeX-S final resultsHenriette Farkas, Jonny G Peter, Marcin Stobiecki, et al.
Autoimmunity Reviews|January 22, 2025
Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disordersFranz Felix Konen, Nora Möhn, Torsten Witte, et al.
The Journal of Allergy and Clinical Immunology|April 23, 2016
Hematopoietic stem cell transplantation for CTLA4 deficiencyMary A Slatter, Karin R Engelhardt, Lauri M Burroughs, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 27, 2025
Oral berotralstat for hereditary angioedema prophylaxis in patients aged 2 to <12 years: APeX-P interim resultsJolanta Bernatoniene, Mélisande Bourgoin-Heck, Mauro Cancian, et al.
Transplantation Proceedings|March 29, 2022
Humoral Response to the Third Dose of Sars-Cov-2 Vaccine in Kidney Transplant RecipientsAyelet Grupper, Liane Rabinowich, Merav Ben-Yehoyada, et al.
Pageof 10

Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
The Journal of Allergy and Clinical Immunology|April 17, 2021
Molecular diagnosis of childhood immune dysregulation, polyendocrinopathy, and enteropathy, and implications for clinical managementSarah K Baxter, Tom Walsh, Silvia Casadei, et al.
Neurological Research and Practice|July 17, 2025
Management of disease-modifying therapies in multiple sclerosis and comorbid rheumatoid arthritisFranz Felix Konen, Torsten Witte, Diana Ernst, et al.
Autoimmunity Reviews|March 16, 2023
Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disordersFranz Felix Konen, Nora Möhn, Torsten Witte, et al.
Science Translational Medicine|June 5, 2020
Gene editing to induce FOXP3 expression in human CD4<sup>+</sup> T cells leads to a stable regulatory phenotype and functionYuchi Honaker, Nicholas Hubbard, Yufei Xiang, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 20, 2022
The effect of a third-dose BNT162b2 vaccine on anti-SARS-CoV-2 antibody levels in immunosuppressed patientsEsther Saiag, Ayelet Grupper, Irit Avivi, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 9, 2025
Long-term safety and efficacy of once-daily berotralstat in patients with hereditary angioedema: APeX-S final resultsHenriette Farkas, Jonny G Peter, Marcin Stobiecki, et al.
Autoimmunity Reviews|January 22, 2025
Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disordersFranz Felix Konen, Nora Möhn, Torsten Witte, et al.
The Journal of Allergy and Clinical Immunology|April 23, 2016
Hematopoietic stem cell transplantation for CTLA4 deficiencyMary A Slatter, Karin R Engelhardt, Lauri M Burroughs, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 27, 2025
Oral berotralstat for hereditary angioedema prophylaxis in patients aged 2 to <12 years: APeX-P interim resultsJolanta Bernatoniene, Mélisande Bourgoin-Heck, Mauro Cancian, et al.
Transplantation Proceedings|March 29, 2022
Humoral Response to the Third Dose of Sars-Cov-2 Vaccine in Kidney Transplant RecipientsAyelet Grupper, Liane Rabinowich, Merav Ben-Yehoyada, et al.
Pageof 10